NYSE · SIC 3841
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Stryker Corporation operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Medsurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products. The Orthopsurgery segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $14.4B | $17.1B | $18.4B | $20.5B | $22.6B | $25.1B |
| Gross profit | $9.1B | $11.0B | $11.6B | $13.1B | $14.4B | $16.1B |
| Operating income | $2.2B | $2.6B | $2.8B | $3.9B | $3.7B | $4.9B |
| Net income | $1.6B | $2.0B | $2.4B | $3.2B | $3.0B | $3.2B |
| Diluted EPS | $4.20 | $5.21 | $6.17 | $8.25 | $7.76 | $8.40 |
| Operating cash flow | $3.3B | $3.3B | $2.6B | $3.7B | $4.2B | $5.0B |
| Free cash flow | $2.8B | $2.7B | $2.0B | $3.1B | $3.5B | $4.3B |
| Gross margin | 63.1% | 64.1% | 62.8% | 63.7% | 63.9% | 64.0% |
| Operating margin | 15.5% | 15.1% | 15.4% | 19.0% | 16.3% | 19.5% |
| Net margin | 11.1% | 11.7% | 12.8% | 15.4% | 13.2% | 12.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4B | $5.5B | $6.4B | $5.9B | $6.0B | $6.1B | $7.2B | $6.0B |
| Gross profit | $3.4B | $3.5B | $4.2B | $3.7B | $3.8B | $3.9B | $4.6B | $3.8B |
| Operating income | $1.1B | $1.1B | $581.0M | $837.0M | $1.1B | $1.1B | $1.8B | $936.0M |
| Net income | $825.0M | $834.0M | $546.0M | $654.0M | $884.0M | $859.0M | $849.0M | $745.0M |
| Diluted EPS | $2.14 | $2.16 | $1.41 | $1.69 | $2.29 | $2.22 | $2.20 | $1.93 |
| Operating cash flow | $633.0M | $1.5B | $1.9B | $250.0M | $1.1B | $1.5B | $2.1B | $581.0M |
| Free cash flow | $481.0M | $1.3B | $1.7B | $127.0M | $928.0M | $1.4B | $1.9B | $415.0M |
| Gross margin | 63.0% | 64.0% | 64.9% | 63.8% | 63.8% | 63.6% | 64.5% | 63.3% |
| Operating margin | 19.4% | 19.7% | 9.0% | 14.3% | 18.5% | 18.7% | 25.2% | 15.5% |
| Net margin | 15.2% | 15.2% | 8.5% | 11.1% | 14.7% | 14.2% | 11.8% | 12.4% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-01 | Stiles Spencer S· President and COO | Gift | 1,607 | $0.00 | $0.00 | filing |
| 2026-05-28 | Fletcher Robert S· VP, Chief Legal Officer | Sale | 2,809 | $306.56 | $861,138.28 | filing |
| 2026-05-28 | Fletcher Robert S· VP, Chief Legal Officer | Sale | 1,067 | $307.30 | $327,885.90 | filing |
| 2026-05-28 | Fletcher Robert S· VP, Chief Legal Officer | Sale | 258 | $308.79 | $79,666.53 | filing |
| 2026-05-28 | Fletcher Robert S· VP, Chief Legal Officer | Sale | 165 | $305.66 | $50,433.90 | filing |
| 2026-05-28 | Fletcher Robert S· VP, Chief Legal Officer | Sale | 125 | $310.22 | $38,777.50 | filing |
| 2026-05-28 | Fletcher Robert S· VP, Chief Legal Officer | Sale | 120 | $304.23 | $36,507.00 | filing |
| 2026-05-26 | STRYKER RONDA E | Sale | 115,960 | $311.60 | $36.1M | filing |
| 2026-05-26 | STRYKER RONDA E | Sale | 114,059 | $312.44 | $35.6M | filing |
| 2026-05-26 | STRYKER RONDA E | Sale | 44,060 | $313.35 | $13.8M | filing |
| 2026-05-26 | STRYKER RONDA E | Sale | 21,807 | $310.77 | $6.8M | filing |
| 2026-05-26 | STRYKER RONDA E | Sale | 10,407 | $314.38 | $3.3M | filing |
| 2026-05-26 | STRYKER RONDA E | Sale | 3,707 | $315.11 | $1.2M | filing |
| 2026-05-11 | Fink M Kathryn· VP, Chief HR Officer | Sale | 5,220 | $283.85 | $1.5M | filing |
| 2026-05-11 | Fink M Kathryn· VP, Chief HR Officer | Sale | 3,500 | $283.45 | $992,085.50 | filing |
| 2026-05-08 | Fink M Kathryn· VP, Chief HR Officer | Tax withholding | 16,362 | $294.23 | $4.8M | filing |
| 2026-05-08 | Fink M Kathryn· VP, Chief HR Officer | Option exercise | 11,850 | $179.35 | $2.1M | filing |
| 2026-05-08 | Fink M Kathryn· VP, Chief HR Officer | Option exercise | 9,732 | $154.14 | $1.5M | filing |
| 2026-05-06 | Skeete Tatum Lisa M | Award | 762 | $0.00 | $0.00 | filing |
| 2026-05-06 | Silvernail Andrew K | Award | 762 | $0.00 | $0.00 | filing |
| 2026-05-06 | Ruggeri Rachel | Award | 762 | $0.00 | $0.00 | filing |
| 2026-05-06 | McCoy Sherilyn S | Award | 762 | $0.00 | $0.00 | filing |
| 2026-05-06 | Maceda Emmanuel Perez | Award | 762 | $0.00 | $0.00 | filing |
| 2026-05-06 | Caforio Giovanni | Award | 762 | $0.00 | $0.00 | filing |
| 2026-05-06 | BRAINERD MARY K | Award | 762 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.